Mark Gauthier

Mark Gauthier has extensive experience in regulatory affairs and science, with over 40 years of experience in the field. Mark began their career as a Research Associate at GD Searle & Co. in 1974. Mark then worked as a Regulatory Affairs Manager at The Upjohn Company from 1985 to 1995. Following this, they joined Immunex as a Regulatory Affairs Manager and stayed there until 2001. From 2001 to 2010, they held various positions at ZymoGenetics, including Manager, Associate Director, and Director of Regulatory Affairs. Mark then served as the Director of Regulatory Affairs at Acucela Inc. from 2010 to 2012. Mark Gauthier continued to climb the corporate ladder and became the Director of Regulatory Affairs at Cell Therapeutics, Inc. in 2012. Mark was later promoted to VP of Regulatory Affairs in 2013 and held that position until 2016. Mark then took the role of VP of Regulatory Affairs & Quality at Nohla Therapeutics from 2016 to 2017. Mark Gauthier joined Dendreon in 2017 as a Senior Director of Regulatory Affairs until 2018 when they transitioned to their current role as Senior Director of Regulatory Science at Voisin Consulting Life Sciences (VCLS).

Mark Gauthier holds a Bachelor of Science degree in biology from Northeastern Illinois University. Mark also has an Associate of Applied Science degree in Industrial Chemistry Technology from Ferris State University.